20 February 2026 in British Journal of Clinical Pharmacology
Aim: The quantitative effect of several inhibitory drugs on the development of adverse drug reactions (ADRs) is currently difficult to estimate. Our aim was to identify metabolic pathways, which, when inhibited, increase the risk for certain ADRs, and to use this system to consider comedication at individual level. Methods: Data of a prospective multicentre cohort of ADRs on emergency department admissions were used (ADRED‐study, trial registration: DRKS00008979). A score system to rate the burden of inhibition on pathways was implemented to calculate individual burdens per patient. These cumulative burden scores were used as predictors in binary logistic regressions to identify pathways, which were significantly positively correlated with the ADRs falls and haemorrhages, respectively. Results: Regarding falls, CYP2D6, OCT2 and carboxylesterase 1 were identified as relevant metabolic pathways with cumulative inhibitory burden. Concerning haemorrhages, CYP2C19, CYP3A4, MRP4, OAT2, OATP1B1 and carboxylesterase 1 were determined. Within relevant pathways for the occurrence of falls, common fall‐risk‐increasing drugs (FRIDs) and associated drugs were found, as well as bleeding inducing drugs within relevant pathways for the occurrence of haemorrhages. Conclusion: Our approach identifies plausible inhibited pathways, raising awareness that a high burden of pathway inhibition can contribute to the occurrence of ADRs. Further validation in a second dataset is necessary.
7 November 2026 in BMC Medicine
Background: Rising ambient temperatures and increasing thermal stress are major public health challenges, associated with increased emergency department (ED) visits in Europe. Frequently prescribed diuretics may exacerbate heat-related risks through mechanisms such as dehydration and electrolyte imbalance. Although many studies have shown a connection between temperature and mortality, the effect of cumulative ambient temperature on diuretic-associated adverse drug reactions (ADRs) remains underexplored. This study investigates whether higher temperatures are associated with an increase in diuretic-related ADRs in ED admissions. Methods: Data from a prospective, observational study on ADRs leading to ED admission (ADRED-study) with a standardized causality assessment of documented drugs were analyzed. Linear, polynomial, and segmented regression were applied to quantify the relationship between 5-day mean temperature and the ratio of suspected diuretic-related ADRs to all diuretic uses. Results: A significant relationship between higher 5-day mean temperatures and more diuretic-associated ADRs was found in linear regression analysis (β = 0·0035, 95%CI: 0·0015 − 0·0054, R²=0·188). A segmented regression model identified a critical threshold of ~ 15·7 °C (adjusted R 2 = 0·382). After the threshold at higher temperatures, the slope for diuretic-associated ADRs increased significantly (β = 0·0201, 95%CI: 0·0068–0·0333). The spline model similarly showed a high statistical fit (adjusted R 2 = 0·399), indicating a non-linear, accelerating increase in ADRs at higher temperatures. Conclusions: Diuretic-associated ADRs increase non-linearly with ambient temperature, with a breakpoint at approximately 15·7 °C. Especially diuretic-medicated individuals may be vulnerable to cumulative thermal stress. Trial registration: The ADRED-study was registered in the German Clinical Trials Register under DRKS00008979.